School of Medicine researchers are cited for studying how insurance coverage affects patient mortality.
Health & Medicine
Arthur Caplan of the School of Medicine discusses Craig Venter’s findings.
Arthur Caplan of the School of Medicine discusses ethical issues surrounding new genetic engineering discoveries.
Arthur Caplan of the School of Medicine discusses Craig Venter and what his accomplishment means to science.
Arthur Caplan of the School of Medicine says, “The FDA should keep a ‘close eye’ on commercial gene tests.”
PHILADELPHIA –- An international collaboration led by chemists and engineers from the University of Pennsylvania has prepared a library of synthetic biomaterials that mimic cellular membranes and that show promise in targeted delivery of cancer drugs, gene therapy, proteins, imaging and diagnostic agents and cosmetics safely to the body in the emerging field called nanomedicine.
The study appears in the current issue of the journal Science.